TMRW Life Sciences vs CoverMyMeds
Side-by-side comparison of AI visibility scores, market position, and capabilities
TMRW Life Sciences builds AI-powered storage and tracking technology for IVF clinics that ensures embryo identity through automated monitoring and chain-of-custody verification.
About
TMRW Life Sciences is a medical technology company founded in 2018 that has raised $75M to build automated storage and tracking systems for fertility clinics that protect the identity and safety of eggs and embryos during IVF treatment. The company's core product is an intelligent storage system that uses barcoded vitrification devices, automated ID verification at every handling step, and continuous environmental monitoring to ensure that embryos are stored at optimal conditions and that identity errors — which can have devastating consequences — are eliminated. TMRW uses machine learning to analyze embryo images and storage conditions, providing fertility clinics with quality control data that was previously impossible to collect at this scale. The company has deployed systems at leading fertility clinic networks across the United States and internationally. TMRW addresses a critical patient safety need as IVF volumes have grown dramatically and clinics have struggled to maintain chain-of-custody integrity with manual processes. The platform also provides operational efficiency benefits for clinic staff and generates data that can be used to improve embryo culture protocols and predict embryo viability.
Largest prior authorization network in the US connecting 75K+ pharmacies, 750K+ providers, and all payers. Columbus OH; acquired by McKesson; available free to providers and pharmacies; processes millions of PA requests annually for specialty and retail prescriptions at no provider cost.
About
CoverMyMeds is the largest prior authorization platform in the United States, operating a network that connects more than 750,000 providers, 75,000 pharmacies, and virtually all payers to streamline the authorization process for prescription medications. Founded in 2008 in Columbus, Ohio, and acquired by McKesson Corporation in 2017, CoverMyMeds processes millions of prior authorization requests annually and has become foundational infrastructure for the US pharmacy and specialty medication market. The platform is available at no cost to providers and pharmacies and is funded through health plan and PBM partnerships.\n\nCoverMyMeds' network effect is central to its value: because the platform is used by the vast majority of pharmacies and a very large share of prescribing providers, payers can reach their entire provider and pharmacy network through a single connection. The platform supports real-time benefit checks that show the formulary status and prior authorization requirements for a drug at the point of prescribing, enabling providers to make more informed prescribing decisions before a patient reaches the pharmacy counter. Automated electronic prior authorization (ePA) workflows reduce approval times from days to hours for eligible drug-payer combinations.\n\nAs part of McKesson, CoverMyMeds has expanded its capabilities to include specialty medication access solutions, patient assistance program enrollment, and medication adherence tools. The company's RxCrossroads subsidiary provides hub services for specialty pharmaceutical manufacturers, creating a comprehensive access ecosystem that spans from initial authorization through patient support and adherence management.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.